News NVIDIA sinks $2bn into AI cloud provider Nebius NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.
News Sanofi says drug for rare disease AATD tops standard care After a phase 2 readout, Sanofi is charting a route to market for AATD therapy efdoralprin alfa, acquired as part of its $2.2bn takeover of Inhibrx.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
